Abbott Laboratories (ABT)

Exchange: New York Stock Exchange

 
Price: 85.42 (Close)

Summary

 

52 Week range 200d Moving Avg. Beta
61.26 – 85.65 74.52 1.03
Dividend Dividend Yield Ex-Dividend date
1.20 1.40% 2019-07-12
P/E Ratio Latest EPS Latest EPS Date
57.53 1.33 2018-12-31
Dividend Aristocrat

Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

 

Sector: Industry:
Health Technology Medical Specialties

 

Abbott Laboratories (ABT) Performance

The chart below displays the performance (%) of Abbott Laboratories for different periods:

 


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
1.40 1.20 90.23% 5 Years

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2019 0.640 -%
2018 1.120 5.7%
2017 1.060 1.9%
2016 1.040 8.3%
2015 0.960 9.1%
2014 0.880 57.1%
2013 0.560 -41.9%
2012 0.964 6.9%
2011 0.902 9.3%
2010 0.825 10.3%
2009 0.748 11.0%
2008 0.674 10.6%
2007 0.609 9.5%
2006 0.557 6.9%
2005 0.521 9.3%

Abbott Laboratories (ABT) Dividend Payment History